Literature DB >> 8587124

Comparative analysis of Homo sapiens and Mus musculus cyclin-dependent kinase (CDK) inhibitor genes p16 (MTS1) and p15 (MTS2).

P Jiang1, S Stone, R Wagner, S Wang, P Dayananth, C A Kozak, B Wold, A Kamb.   

Abstract

Cyclin-dependent kinase inhibitors are a growing family of molecules that regulate important transitions in the cell cycle. At least one of these molecules, p16, has been implicated in human tumorigenesis while its close homolog, p15, is induced by cell contact and transforming growth factor-beta (TGF-beta). To investigate the evolutionary and functional features of p15 and p16, we have isolated mouse (Mus musculus) homologs of each gene. Comparative analysis of these sequences provides evidence that the genes have similar functions in mouse and human. In addition, the comparison suggests that a gene conversion event is part of the evolution of the human p15 and p16 genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587124     DOI: 10.1007/bf00173159

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  34 in total

1.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

Review 3.  Gene conversion: some implications for immunoglobulin genes.

Authors:  D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

4.  Identification of genes from pattern formation, tyrosine kinase, and potassium channel families by DNA amplification.

Authors:  A Kamb; M Weir; B Rudy; H Varmus; C Kenyon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

6.  A novel p16INK4A transcript.

Authors:  L Mao; A Merlo; G Bedi; G I Shapiro; C D Edwards; B J Rollins; D Sidransky
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

7.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

Authors:  M Serrano; E Gómez-Lahoz; R A DePinho; D Beach; D Bar-Sagi
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

8.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

9.  Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.

Authors:  F K Chan; J Zhang; L Cheng; D N Shapiro; A Winoto
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

10.  Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

Authors:  D Parry; S Bates; D J Mann; G Peters
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  1 in total

1.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.